SymbolLAB
NameSTANDARD BIOTOOLS INC.
SectorINDUSTRIALS
RegionNorth America
IndustryBiotechnology: Laboratory Analytical Instruments
Address2 TOWER PLACE,SUITE 2000, SOUTH SAN FRANCISCO, California, 94080, United States
Telephone+1 650 266-6000
Fax
Email
Websitehttps://www.standardbio.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001162194
Description

Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. Its segments include Proteomics and Genomics. Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. It provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. It works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories around the world, focusing on the needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company distributes its systems through its direct sales force and support organizations.

Additional info from NASDAQ:
Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. Its segments include Proteomics and Genomics. Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. It provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. It works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories around the world, focusing on the needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company distributes its systems through its direct sales force and support organizations.

2026-06-23 21:45

Carey Thomas D. 🟢 acquired 363.0K shares (1 derivative) of STANDARD BIOTOOLS INC. (LAB) at $0.83 Transaction Date: Jun 18, 2026 | Filing ID: 279834

Read more
2026-06-23 21:45

Mackay Sean 🟢 acquired 500.0K shares of STANDARD BIOTOOLS INC. (LAB) Transaction Date: Jun 20, 2026 | Filing ID: 279833

Read more
2026-06-23 21:43

Witney Frank 🟢 acquired 275.0K shares (1 derivative) of STANDARD BIOTOOLS INC. (LAB) at $0.83 Transaction Date: Jun 18, 2026 | Filing ID: 279830

Read more
2026-06-23 21:41

Casdin Eli 🟢 acquired 275.0K shares (1 derivative) of STANDARD BIOTOOLS INC. (LAB) at $0.83 Transaction Date: Jun 18, 2026 | Filing ID: 279828

Read more
2026-06-23 21:41

Cox Troy 🟢 acquired 275.0K shares (1 derivative) of STANDARD BIOTOOLS INC. (LAB) at $0.83 Transaction Date: Jun 18, 2026 | Filing ID: 279827

Read more
2026-06-23 21:39

ELOI FENEL M 🟢 acquired 275.0K shares (1 derivative) of STANDARD BIOTOOLS INC. (LAB) at $0.83 Transaction Date: Jun 18, 2026 | Filing ID: 279824

Read more
2026-06-23 21:39

HIBBS KATHY L 🟢 acquired 275.0K shares (1 derivative) of STANDARD BIOTOOLS INC. (LAB) at $0.83 Transaction Date: Jun 18, 2026 | Filing ID: 279823

Read more
2026-06-15 14:11

LAB Stock Alert: Halper Sadeh LLC is Investigating Whether Standard BioTools Inc. is Obtaining a Fair Price for its Shareholders

Read more
2026-06-12 18:35

New Form SCHEDULE 13D - STANDARD BIOTOOLS INC. <b>Filed:</b> 2026-06-12 <b>AccNo:</b> 0000905148-26-002940 <b>Size:</b> 39 KB

Read more
2026-06-11 11:00

Labrador Gold to Host Investor Webinar on the Mariposa Gold Project in Yukon’s White Gold District

Read more